Life After Loper: Vaping Case Shows US FDA Retains Considerable Deference

Supreme Court’s Wages and White Lion Decision Offers Insight Into FDA Product Approval Processes and May Open The Door To Future Challenges

 
• By Craig Bleifer, Royce DuBiner, Max Bogost, Michael Brody, and Allyson Maur
  
After the Wages and White Lion Investments case, the US FDA is the king of the ‘bad faith’ standard. (Shutterstock)

More from Litigation

More from Pathways & Standards